Autonomous, factor-independent growth and differentiation of malignant cells in preleukemic and leukemic disease states is a well-recognized phenomenon and is often associated with a poor prognosis. Mast cells are distinct hematopoietic cells and express a unique profile of antigens. Growth and differentiation of normal mast cells is dependent on mast cell growth factor (MGF), the ligand of the c-kit protooncogene product. In this study, we screened for mast cell-lineage involvement in 52 patients suffering from myeloid leukemias, myelodysplastic syndromes (MDS), systemic mastocytosis, or other diseases by probing for mast cell-related molecules (c-kit, tryptase, histamine, and MGF) and by analyzing kit ligand/MGF-independent growth of mast cells in long-term suspension culture. Of the 52 patients tested, 2 patients with refractory anemia with excess of blast cells in transformation and 1 patient suffering from chronic myeloid leukemia blast crisis (CML-BC) were diagnosed as mastocytic disease. These patients were characterized by complex chromosomal abnormalities, splenomegaly, high percentages of circulating metachromatic cells (5% to 25%), high levels of cellular tryptase (> 10 ng/10(5) peripheral blood mononuclear cells/mL) and a tryptase/histamine (ng:ng) ratio greater than 1. The metachromatic cells expressed the mast-cell-related surface antigen c-kit, but not basophil-related antigens (CD11b, CDw17). Furthermore, in these 3 patients, spontaneous, MGF-independent growth of mast cells along with spontaneous synthesis of tryptase was demonstrable in long-term culture. No autocrine production, paracrine production, or overproduction of MGF was found. The spontaneous growth of mast cells could neither be abbrogated by addition of monoclonal antibodies (MoAbs) to c-kit nor by MoAbs against MGF (< 5% inhibition), whereas factor (MGF)-dependent differentiation of mast cells in these patients could be abbrogated by MoAbs to c-kit or MoAbs to MGF (> 70% inhibition, P < .001). In addition, serum MGF levels in these patients were within the normal range and MGF could not be detected in cell-free culture supernatants. All 3 patients showed rapid progression of disease and had a survival time of less than 1 year. In conclusion, we describe a unique form of transformation in MDS and CML-BC characterized by mast cell lineage involvement and factor-independent differentiation of mast cells. This form of leukemic transformation has to be delineated from chronic myeloid leukemia with basophilia or basophil crisis, from primary mast cell leukemia, and from monocytic leukemias and myelodysplastic disorders associated with basophilia.
Skip Nav Destination
ARTICLES|
December 15, 1994
Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis
P Valent,
P Valent
Department of Internal Medicine, University of Vienna, Austria.
Search for other works by this author on:
E Spanblochl,
E Spanblochl
Department of Internal Medicine, University of Vienna, Austria.
Search for other works by this author on:
HC Bankl,
HC Bankl
Department of Internal Medicine, University of Vienna, Austria.
Search for other works by this author on:
WR Sperr,
WR Sperr
Department of Internal Medicine, University of Vienna, Austria.
Search for other works by this author on:
C Marosi,
C Marosi
Department of Internal Medicine, University of Vienna, Austria.
Search for other works by this author on:
H Pirc-Danoewinata,
H Pirc-Danoewinata
Department of Internal Medicine, University of Vienna, Austria.
Search for other works by this author on:
I Virgolini,
I Virgolini
Department of Internal Medicine, University of Vienna, Austria.
Search for other works by this author on:
HG Eichler,
HG Eichler
Department of Internal Medicine, University of Vienna, Austria.
Search for other works by this author on:
H Agis,
H Agis
Department of Internal Medicine, University of Vienna, Austria.
Search for other works by this author on:
C Sillaber
C Sillaber
Department of Internal Medicine, University of Vienna, Austria.
Search for other works by this author on:
Blood (1994) 84 (12): 4322–4332.
Citation
P Valent, E Spanblochl, HC Bankl, WR Sperr, C Marosi, H Pirc-Danoewinata, I Virgolini, HG Eichler, H Agis, C Sillaber; Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis. Blood 1994; 84 (12): 4322–4332. doi: https://doi.org/10.1182/blood.V84.12.4322.bloodjournal84124322
Download citation file:
December 15 1994
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal